Lupin, DKSH ink pact to commercialize 5 of Alvotech proposed biosimilars in Philippines Ruchika Sharma7 Sept 2022 11:45 AM ISTThis agreement enhances Multicare's oncology, rheumatology, gastroenterology, and ophthalmology, portfolio, which currently consists of three...
Lupin, Zydus Lifesciences recall products in US over manufacturing issues Ruchika Sharma3 Sept 2022 12:03 PM ISTNew Delhi: Home-grown drug makers Zydus Lifesciences and Lupin are recalling products in the US, the world's largest market for medicines, due to...
Lupin Gets USFDA Nod For Generic Cancer Treatment Drug Kajal Rajput30 Aug 2022 1:29 PM ISTMumbai: Global pharma major Lupin Limited (Lupin) in partnership with Pharmascience Inc. today announced that it has received tentative approval from...
Lupin rolls out Desvenlafaxine ER tablets in US Ruchika Sharma27 Aug 2022 9:30 AM ISTMumbai: Global pharma major, Lupin Limited, has announced the launch of Desvenlafaxine Extended-Release Tablets, 25 mg, having received an approval...
Lupin to acquire diabetes brands Ondero, Ondero-Met from Boehringer Ingelheim for Rs 207 crore Ruchika Sharma25 Aug 2022 3:30 PM ISTNew Delhi: Lupin Limited is soon going to acquire two diabetes brands Ondero and Ondero - Met from Boehringer Ingelheim International GmbH for Rs...
Lupin, I'rom ink pact for biosimilar Denosumab Ruchika Sharma25 Aug 2022 12:30 PM ISTCurrently, Denosumab is available under two brands, Pralia and Ranmark.
Lupin gets USFDA nod for generic equivalent of Mylan Specialty Perforomist Inhalation Solution Ruchika Sharma24 Aug 2022 5:00 PM ISTPERFOROMIST Inhalation Solution is a long-acting beta2-adrenergic agonist (beta2-agonist)
Lupin bags USFDA okay for seizure treatment drug Rufinamide Ruchika Sharma18 Aug 2022 3:23 PM ISTRufinamide Tablets will be manufactured at Lupin’s facility in Goa, India.
Lupin rationalising product portfolio in US to overcome price erosion impact, says CEO Vinita Gupta Ruchika Sharma16 Aug 2022 1:30 PM ISTLupin's transitioning of the portfolio from the simple generic oral solids to complex generics had started with short-acting bronchodilator albuterol.
Lupin bags USFDA nod for Meclizine Hydrochloride Tablets Ruchika Sharma13 Aug 2022 1:00 PM ISTThe product is a generic equivalent of Antivert Tablets, 12.5 mg, 25 mg, and 50 mg, of Casper Pharma LLC.
Lupin secures USFDA nod for Azilsartan Medoxomil Tablets Ruchika Sharma25 July 2022 5:46 PM ISTThe product will be manufactured at Lupin’s facility in Nagpur, India.
Lupin Somerset facility gets EIR from USFDA Rahul Verma9 July 2022 6:30 PM ISTGlobal pharma major, Lupin Limited, today announced that the company has received the Establishment Inspection Report (EIR) from United States Food...
